|

Treatment as Prevention for Hepatitis C in Iceland

RECRUITINGSponsored by Landspitali University Hospital
Actively Recruiting
SponsorLandspitali University Hospital
Started2016-01
Est. completion2021-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02647879

Summary

The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* HCV positive subjects 18 years and older, living in Iceland and covered by the Icelandic Health Insurance.

Exclusion Criteria:

* Age under 18 years
* Inability to sign informed consent.

Conditions2

Hepatitis CLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.